Profile
POAI ISRG BDXA BDX ALC RMD
Company Name Predictive Oncology Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $5.24M $189.34B $55.91B $51.42B $37.61B $36.15B
Employees 0.02K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Raymond F. Vennare Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
POAI ISRG BDXA BDX ALC RMD
Quant Rating Score 2 3 5 3 3 3
Quant Rating Sell Neutral Strong Buy Neutral Neutral Neutral
Trading
POAI ISRG BDXA BDX ALC RMD
Last Close $7.21 $538.82 $59.24 $179.04 $74.19 $246.4
High 52 $14.7 $610.45 $59.24 $249.08 $98.3 $293.73
Low 52 $0.64 $429.59 $59.24 $165.15 $72.05 $204.58
Price vs. 52 Week High -50.95 % -11.73 % 0 % -28.12 % -24.53 % -16.11 %
Price vs. 52 Week Low 1026.56 % 25.43 % 0 % 8.41 % 2.97 % 20.44 %
Total Return
POAI ISRG BDXA BDX ALC RMD
1 Month Return -49.67 % 19.12 % 0 % -7.53 % -4.12 % -11.55 %
3 Month Return 836.49 % 12.97 % 0 % 1.22 % -13.27 % -13.5 %
6 Month Return 576.11 % 1.26 % 0 % 7.21 % -23.81 % 2.39 %
9 Month Return 377.48 % -8.81 % 0 % -26.94 % -20.65 % 1.57 %
YTD Return 779.27 % 3.23 % 0 % -21.08 % -12.6 % 7.74 %
1 Year Return 930 % 4.59 % 0 % -24.55 % -19.74 % 0.27 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
POAI ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) - - 2.33 % 2.32 % 0.44 % 0.89 %
Dividend Paid and Capex Coverage Ration (TTM) -2873709.33 % 4.3 % 1.73 % 1.73 % 3.26 % 4.31 %
Dividend Per Share (TTM) - - 4.16 % 4.16 % 0.33 % 2.19 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 15.71 % 22.31 %
Profitability
POAI ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM 32.62 % 66.41 % 45.08 % 45.08 % 55.13 % 60.08 %
Return on Assets TTM -284.62 % 14.19 % 2.93 % 2.93 % 3.42 % 17.31 %
Return on Equity TTM 112267.06 % 16.08 % 6.31 % 6.31 % 4.93 % 25.13 %
Return on Capital Employed TTM 2288.5 % 16.05 % 5.78 % 5.78 % 4.98 % 24.74 %
Net Income Per EBT TTM 113.05 % 86.77 % 83.91 % 83.91 % 85.57 % 82.6 %
EBT Per Ebit TTM 92.16 % 112.41 % 70.86 % 70.86 % 86.96 % 99.79 %
EBIT Per Revenue TTM -876.84 % 29.3 % 12.63 % 12.63 % 14.38 % 33.18 %
Cash Flow To Debt Ratio TTM -466.97 % - 16.82 % 16.82 % 39.27 % 222.53 %
Receivables Turnover TTM 46.62 7.63 7.27 7.27 4.98 5.79
Payables Turnover TTM 0.54 11.09 1.85 1.85 5.03 7.87
Inventory Turnover TTM 16.89 1.81 2.97 2.97 1.88 2.22
Fixed Asset Turnover TTM 51.93 % 186.61 % 313.67 % 313.67 % 197.54 % 724.52 %
Asset Turnover TTM 31.15 % 49.67 % 38.95 % 38.95 % 31.94 % 63.28 %
Operating Cash Flow Per Share TTM -0.95 8.3 11.3 11.3 4.16 12.86
Free Cash Flow Per Share TTM -0.95 6.37 8.85 8.85 3.23 12.06
Cash Per Share TTM 5.56 % 1376.56 % 262.85 % 262.85 % 284.33 % 944.79 %
Operating Cash Flow Sales Ratio TTM -805.51 % 30.8 % 15.22 % 15.22 % 20.57 % 35.82 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 76.72 % 78.37 % 78.37 % 77.51 % 93.83 %
Cash Flow Coverage Ratios TTM -466.97 % - 16.82 % 16.82 % 39.27 % 222.53 %
Price To Free Cash Flows Ratio TTM -0.61 83.36 20.09 20.16 23.53 20.46
Price To Operating Cash Flows Ratio TTM -7.62 63.84 15.82 15.88 18.27 19.2
Price Cash Flow Ratio TTM -7.62 63.84 15.82 15.88 18.27 19.2
Income Statement (TTM)
POAI ISRG BDXA BDX ALC RMD
Revenue $0B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $0B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 49.12% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $-0.01B $2.81B $4.82B $4.82B $2.68B $1.91B
Net Income $-0.01B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted -2.24 6.42 5.86 5.86 2.05 9.51
Balance Sheet (MRQ)
POAI ISRG BDXA BDX ALC RMD
Long Term Debt $0B $0.11B $18.61B $18.61B $4.97B $0.81B
Total Liabilities $0.01B $2.31B $31.4B $31.4B $8.79B $2.21B
Total Equity $-0B $16.53B $25.89B $25.89B $21.55B $5.97B
Total Investments $0B $7.05B $0.45B $0.45B $0.91B $0.09B
Total Debt $0B $0.15B $20.92B $20.92B $5.14B $0.88B
Total Assets $0B $18.84B $57.29B $57.29B $30.35B $8.17B
Cash Flow Statement (TTM)
POAI ISRG BDXA BDX ALC RMD
Net Income $-0.01B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $0B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $-0.01B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 74.34
ANGO AngioDynamics, Inc. 11.91
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 115.57
ATRC AtriCure, Inc. 32.32
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.58
AZTA Azenta, Inc. 30.54
BAX Baxter International Inc. 17.95
BDX Becton, Dickinson and Company 176.39
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.73
BLFS BioLife Solutions, Inc. 27.57
COO The Cooper Companies, Inc. 68.88
DXR Daxor Corporation 12.76
EKSO Ekso Bionics Holdings, Inc. 5.25
ETFs With Exposure to POAI
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 333.16
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 147.86
VXF Vanguard Extended Market Index Fund 0.00006 209.3
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000926 38.84
VTSAX Vanguard Total Stock Market Index Fund 0 162.15
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00006 158.75
VITSX Vanguard Total Stock Market Index Fund 0 162.17
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00006 158.76
VEMPX Vanguard Extended Market Index InstlPlus 0.00006 391.76
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 304.22
Unlock